Evidence map›Paper›PMID 37171855›Full record

ArticleMicrobial genomics2023

Genomic analysis of 1710 surveillance-based

Jennifer L Reimche, Arvon A Clemons, Vasanta L Chivukula, Sandeep J Joseph, Matthew W Schmerer, Cau D Pham, Karen Schlanger, Sancta B St Cyr, Ellen N Kersh, Kim M Gernert and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Heterogeneity of azithromycin resistance markers inNew microbes and new infections · 2026
    Review
  2. Article
  3. Establishing aMicrobiology spectrum · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. CommensalAnnual review of microbiology · 2025
    Review
  8. Susceptibility ofPathogens (Basel, Switzerland) · 2025
    Article
  9. Tetracycline-resistantJAC-antimicrobial resistance · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Local emergence and global evolution ofAntimicrobial agents and chemotherapy · 2024
    Article
  14. Emergence and evolution of mosaicFrontiers in microbiology · 2024
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jennifer L ReimcheDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Arvon A ClemonsDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Vasanta L ChivukulaOak Ridge Institute for Science and Education Research Participation and Fellowship Program, Oak Ridge, TN, USA.
Sandeep J JosephDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Matthew W SchmererDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Cau D PhamAntimicrobial Resistance Coordination and Strategy Unit, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Karen SchlangerDivision of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Sancta B St CyrDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ellen N KershDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kim M GernertDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Antimicrobial-Resistant Working Group
Centers for Disease Control and Prevention · USOak Ridge Associated Universities · US

Funding

CDC HHS
6 · The paper itself

Abstract

This study characterized high-quality whole-genome sequences of a sentinel, surveillance-based collection of 1710

Indexed as

Anti-Infective AgentsGonorrheaAnti-Bacterial AgentsAzithromycinCefiximeCeftriaxoneCiprofloxacinGenomicsHumansMitomycinNeisseria gonorrhoeaePhylogenyRNA, Ribosomal, 23SAnti-Bacterial AgentsAnti-Infective AgentsAzithromycinCefiximeCeftriaxoneCiprofloxacinMitomycinRNA, Ribosomal, 23S(3-6) antimicrobial resistancemolecular epidemiologyNeisseria gonorrhoeaesurveillancewhole-genome sequencing

Identifiers

PMID37171855
PMCPMC10272886
OpenAlexW4376226314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.